|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 720 GMAT Classic | 5 | Healthcare/Pharmaceuticals | India |
24 Oct 2023 09:51 AM
|
|
| Full Time MBA |
Admitted, ($$$)
|
Round 2 | 2024 | 735 GMAT Focus 780 GMAT Classic |
2.3 | 5 | Computer Software | India |
24 Oct 2023 07:32 AM
|
| Full Time MBA |
Admitted, ($)
|
Round 1 | 2024 | 750 GMAT Classic | 3.2 | 5 | Other | India |
24 Oct 2023 02:22 AM
|
| Full Time MBA |
Admitted
|
Round 1 | 2024 | 720 GMAT Classic 750 GMAT Classic |
4 | 9 | Consulting | India |
21 Oct 2023 11:34 PM
|
| Full Time MBA |
Invited to Interview
|
Early Action | 2022 | 710 GMAT Classic 760 GMAT Classic |
3.7 | 8 | Consulting | India |
20 Oct 2023 02:09 PM
|
| Full Time MBA |
Admitted
|
Round 1 | 2024 | 700 GMAT Classic 730 GMAT Classic 335 GRE |
3 | 5 | Consulting | India |
20 Oct 2023 02:07 PM
|
| Full Time MBA |
Denied with Interview
|
Round 1 | 2024 | 760 GMAT Classic | 7 | Consulting | United States |
20 Oct 2023 02:06 PM
|
|
| Full Time MBA |
Admitted, ($)
|
Round 1 | 2024 | 700 GMAT Classic | 6 | Finance: Investment Banking | United States |
20 Oct 2023 01:14 PM
|
|
| Full Time MBA |
Admitted, ($)
|
Round 1 | 2024 | 315 GRE | 3.4 | 10 | Healthcare/Pharmaceuticals | United States |
20 Oct 2023 05:30 AM
|
| Full Time MBA |
Admitted, ($$)
|
Round 1 | 2024 | 700 GMAT Classic 750 GMAT Classic |
3.2 | 2 | Consulting | India |
20 Oct 2023 04:33 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2024 | 336 GRE | 3.8 | 3 | Consulting | Canada |
19 Oct 2023 07:55 PM
|
| Full Time MBA |
Admitted
|
2004 | 332 GRE | 3.5 | 5 | Healthcare/Pharmaceuticals | Colombia |
19 Oct 2023 03:58 PM
|
|
| Full Time MBA |
Admitted, ($$)
|
Round 2 | 2024 | 332 GRE | 3.5 | 5 | Healthcare/Pharmaceuticals | Colombia |
19 Oct 2023 03:57 PM
|
| Full Time MBA |
Admitted, ($$)
|
2024 | 3.7 | 5 | Consulting | India |
19 Oct 2023 10:06 AM
|
||
| Full Time MBA |
Interviewed
|
Round 1 | 2024 | 316 GRE | 3.4 | 4 | Consulting | United States |
18 Oct 2023 12:27 PM
|
| Full Time MBA |
Denied with Interview
|
Early Action | 2023 | 740 GMAT Classic | 4 | 5 | Other | India |
13 Oct 2023 12:26 AM
|
| Full Time MBA |
Interviewed
|
2024 | 315 GRE | 3.9 | 8 | Retail: E-commerce | India |
12 Oct 2023 02:07 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2024 | 710 GMAT Classic | 3.3 | 5 | Consulting | India |
26 Sep 2023 08:03 AM
|
| Full Time MBA |
Matriculating, ($$$)
|
Round 2 | 2022 | 710 GMAT Classic 740 GMAT Classic |
8 | Other | United States |
14 Sep 2023 02:09 PM
|
|
| Full Time MBA |
Matriculating, ($$)
|
Round 2 | 2022 | 710 GMAT Classic | 3.9 | 3 | Other | United States |
19 Jul 2023 08:43 AM
|